Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$380K Sell
2,498
-2,398
-49% -$400K ﹤0.01% 552
2026
Q1
$1.03M Sell
4,896
-115
-2% -$28.9K 0.01% 363
2025
Q4
$1.42M Buy
+5,011
New +$1.57M 0.01% 315

Other funds holding PODD

TCW Group's PODD Position: Q2 2026 in Review

TCW Group reduced its Insulet (PODD) stake by 49% in Q2 2026, selling an estimated $400K and leaving 2,498 shares worth $380K. The position accounts for ﹤0.01% of the portfolio, ranked #552.

TCW Group first reported a position in PODD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.42M in Q4 2025. 727 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • TCW Group held 2,498 shares of Insulet worth $380K as of Q2 2026.
  • TCW Group sold 2,398 Insulet shares in Q2 2026, an estimated $400K.
  • Insulet made up ﹤0.01% of TCW Group's portfolio in Q2 2026, its #552 holding.
  • TCW Group first reported a position in Insulet in Q4 2025 and has held it in 3 quarters since.
  • TCW Group's Insulet position peaked at $1.42M in Q4 2025.
  • 727 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on TCW Group's 13F filing for Q2 2026, filed 3 Aug 2026.